InsidersTradesSigma
Follow the IBA share price and the full insider trade history of the company, a listed equity based in Belgium. Shares are listed on BE BE, under the supervision of FSMA. Market capitalisation: €490.8m. The latest transaction was disclosed on 18 February 2026 (Sale). Among the most active insiders: Robberechts Bart. The full history is free.
51
Insider Decl.
0
Thresholds
€908,446
39 ops.
Buy Volume
€1m
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate IBA Buy (bullish), based on 4 analysts. Average price target: €15.75.
16Σ signal
Fundamental score
Ranked 18,070 of 26,034 companies
38.9
score / 100
Value33
Quality45
FCF yld-7.8%
Earn yld2.6%
EV/EBITDA16.6x
ROE11%
Gross mgn32%
Net mgn2.1%
Debt/EBITDA3.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 February 2026
Declarations51 total
2,500 shares@ €7.4549.9% of flowShareEuronext BrusselsFSMA:iba-45
2,500 shares@ €7.5450.1% of flowShareEuronext BrusselsFSMA:iba-81
Ideal exit: 23 Oct 2026 (T+270)
5,916 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-73
Ideal exit: 27 Mar 2026 (T+270)
5,000 shares@ €15.4143.0% of flowShareEuronext BrusselsFSMA:iba-17
19,721 shares@ €11.4850.9% of flowShareEuronext BrusselsFSMA:iba-76
Ideal exit: 31 Mar 2026 (T+270)
19,721 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-77
Ideal exit: 31 Mar 2026 (T+270)
10,000 shares@ €11.6729.8% of flowShareEuronext BrusselsFSMA:iba-80
5,000 shares@ €7.5411.6% of flowShareEuronext BrusselsFSMA:iba-79
Ideal exit: 21 Feb 2026 (T+270)
10,000 shares@ €7.5419.3% of flowShareEuronext BrusselsFSMA:iba-88
Ideal exit: 27 Sept 2026 (T+270)
9,861 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-87
Ideal exit: 31 Mar 2026 (T+270)
9,861 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-82
Ideal exit: 31 Mar 2026 (T+270)
9,861 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-11
Ideal exit: 31 Mar 2026 (T+270)
13,000 shares@ €10.2240.7% of flowShareEuronext BrusselsFSMA:iba-41
Ideal exit: 2 Jan 2026 (T+270)
19,721 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-16
Ideal exit: 31 Mar 2026 (T+270)
9,861 shares0Options /warrants for employees or managersOff exchangeFSMA:iba-78
Ideal exit: 31 Mar 2026 (T+270)
20,000 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-5
Ideal exit: 8 Oct 2024 (T+270)
12,500 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-13
Ideal exit: 3 Feb 2026 (T+270)
13,297 shares@ €11.7047.7% of flowShareEuronext BrusselsFSMA:iba-72
20,000 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-9
Ideal exit: 6 May 2025 (T+270)
5,916 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-85
Ideal exit: 27 Mar 2026 (T+270)
9,861 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-71
Ideal exit: 31 Mar 2026 (T+270)
9,861 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-67
Ideal exit: 31 Mar 2026 (T+270)
78,885 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-83
Ideal exit: 31 Mar 2026 (T+270)
19,721 shares0Options /warrants for employees or managersEuronext BrusselsFSMA:iba-66
Ideal exit: 31 Mar 2026 (T+270)
25 of 51 declarations
About IBA
IBA is a company listed on the XBRU market, specializing in the development of radiation therapy and nuclear medicine solutions.